Clariant holds majority share in Sued-Chemie

Published: 26-Apr-2011
Ingredients

Having closed the deal it will make a public offer to acquire the outstanding shares


Specialty chemicals provider Clariant has completed the purchase of 96,15% of the shares in Süd-Chemie from One Equity Partners and the family shareholders.

Clariant will make a public offer to acquire the outstanding shares from Süd-Chemie minority shareholders. The overall transaction value amounts to approx.€1.9 bn (£1.68 bn).

‘This transaction is an important milestone in Clariant’s history. Following the successful completion of our restructuring in 2010, the acquisition of Süd-Chemie accelerates our strategy of profitable growth’, said Hariolf Kottmann, ceo of Clariant. ‘Together we will now start the integration process to successfully integrate Süd-Chemie into Clariant’, Kottmann added.

By acquiring leading positions in the fields of process catalysts and adsorbent agents, Clariant is expanding its portfolio with two fast-growing business-units. Headquartered in Germany, Süd-Chemie also has a strong r&d organisation focusing on market segments with significant growth potential.



See more

You may also like

Ingredients

Clariant sales soar 16% in 2011

Read more
Boosted by 21% growth in Q4

Trending Articles

  1. Causes and solutions for dark spots in tablet manufacturing Natoli Engineering examines the causes and solutions for dark spots that can halt production
  2. CordenPharma & GENEPEP collaborate to leverage peptide drug substance discovery The partnership has facilitated the expedition of the development, discovery and manufacturing of peptides for early clinical phase
  3. The evolution of the pharma industry: From reactive to disruptive Globally, the pharma industry has witnessed waves of changes during the last century; we have evolved, writes Ajit Kanetkar, Head, Process Technology, ACG, from maintaining a conservative outlook and being solely reactive to disease and healthcare issues to having a radical and disruptive approach
  4. Highly potent APIs: Hazards in classification and handling This variability and subjective nature of classification means that the OEL is best considered as a tool for site risk management teams
  5. Rousselot announces access to pure gelatins through BIO INX Research and technical grade gelatins are now available for online purchase in Canada, Europe, South Korea and the US

Upcoming event

Cleanroom Conference UK

22–23 May 2024 | Exhibition | Birmingham, UK See all

You may also like

Ingredients

Clariant sales soar 16% in 2011

Boosted by 21% growth in Q4
Ingredients

Clariant Q2 results hold steady

Growth adversely affected by Swiss franc appreciation
Manufacturing

Clariant plans acquisition of Süd-Chemie

Turns 2009 net loss into net income of CHF180m
Ingredients

Clariant to build innovation centre

To be located in Frankfurt, Germany
Ingredients

Clariant opens China HQ in Shanghai

Also starts up pigment joint venture
Ingredients

Clariant cuts more jobs as recession bites

Clariant, the Swiss producer of specialist chemicals, is to cut 500 jobs as it reported an 18% fall in sales to CHF6.6bn (
Ingredients

Stand-alone Archimica emphasises its pharma focus

Archimica, formerly the Pharmaceutical Fine Chemicals business of Clariant, goes it alone
Subscribe now